Publication | Closed Access
Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation
30
Citations
25
References
2022
Year
Cell TherapyTransplantationMarrow TransplantationFlt3-itd Mutant LeukemiaStem Cell TransplantationImmunologyHematologyGraft-versus-leukemia EffectsGraft SurvivalCell TransplantationBlood TransplantationMedicineCell BiologyGraft Rejection
| Year | Citations | |
|---|---|---|
Page 1
Page 1